proteasome inhibitors (Evestra)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameproteasome inhibitors (Evestra)
Drug Alias NamePS-341-BP-2PS-341-BP-1MG-262-BP
ClassificationSmall molecules
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvestra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvestra Inc
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A